Owner NOVARTIS AG

Inventors CERWENKA, Adelheid; KALTHOFF, Frank, Stephan; PHARES, William, F.

Pub. Number AU-A-2002327879

PCT Number PCT/EP02/07924

PCT Pub. Number WO2003/008579

Priority 60/305,932 17.07.01 US; 60/313,550 20.08.01 US; 60/315,123 27.08.01 US; 60/318,484 10.09.01 US

Filing date 16 July 2002

Wipo publication date 3 March 2003

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

A61P 035/00 Antineoplastic agents

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 014/47 Peptides having more than 20 amino acids

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 038/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 031/7088 - Compounds having three or more nucleosides or nucleotides

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 037/00 Drugs for immunological or allergic disorders